FDA clears Siemens' AI for PET/CT

2019 12 03 17 03 9108 Siemens Rsna 2019 400

Siemens Healthineers has received clearance from the U.S. Food and Drug Administration (FDA) for its AIDAN artificial intelligence (AI) technology for the Biograph PET/CT product line.

AIDAN includes four new features:

  • FlowMotion AI uses continuous bed motion with the company's proprietary Alpha AI technology to automatically detect anatomical structures and automatically apply disease-specific protocol parameters based on individual requirements.
  • PET FAST WorkFlow AI is designed to automate post-scan tasks by automatically performing fast image transfer and auto data export to create PACS-ready data ranges.
  • OncoFreeze AI also uses Alpha technology and algorithms to acquire PET/CT images without the adverse effects of respiratory motion and no additional scan time.
  • Multiparametric PET Suite AI offers a fully automated workflow to extract the arterial input function automatically from acquired PET/CT images without the unnecessary risk associated with arterial lines and sampling.

Aiden AI also offers enhanced protection against cyberthreats through syngo Security software.

Page 1 of 593
Next Page